The device has been usesd in more than 15,000 cases globally, according to a news release. It features a wide range of implants for interbody fusion.
Implanet’s CEO, Ludovic Lastennet, said SqualeTM is expected to launch in the U.S. by summer.
Implanet’s new cervical spine device earns FDA nod
Implanet’s SqualeTM anterior cervical cage received FDA 510(k) approval, the devicemaker said April 11.
From repetitive to real-time: AI that lightens the back-office load
Recommended Live Webinar on Jan 22, 2026 12:00 PM - 1:00 PM CST